One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-134189
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 6 |
Affiliation: Hackensack University Medical Center, University of California, Los Angeles, Cleveland Clinic, McGill University, University of Kansas Cancer Center, Colorado Blood Cancer Institute, Vancouver General Hospital, Puerto Rico Community Foundation, Tennessee Oncology, Florida Cancer Specialists & Research Institute, Princess Margaret Cancer Centre, Bristol-Myers Squibb (Italy), Bristol-Myers Squibb (United States), Baker Hughes (Canada)Pomalidomide, Dexamethasone, and Daratumumab after Lenalidomide Treatment in Relapsed Refractory Multiple Myeloma: Updated Results from an Open-Label, Multicenter, Phase 2 Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
